|
1
|
Azziz R, Carmina E, Chen Z, Dunaif A,
Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ and
Yildiz BO: Polycystic ovary syndrome. Nat Rev Dis Primers.
2:160572016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amato MC, Vesco R, Vigneri E, Ciresi A and
Giordano C: Hyperinsulinism and polycystic ovary syndrome (PCOS):
role of insulin clearance. J Endocrinol Invest. 38:1319–1326. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Diamanti-Kandarakis E and Dunaif A:
Insulin resistance and the polycystic ovary syndrome revisited: an
update on mechanisms and implications. Endocr Rev. 33:981–1030.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ford ES: The metabolic syndrome and
mortality from cardiovascular disease and all-causes: findings from
the National Health and Nutrition Examination Survey II Mortality
Study. Atherosclerosis. 173:309–314. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Polak K, Czyzyk A, Simoncini T and
Meczekalski B: New markers of insulin resistance in polycystic
ovary syndrome. J Endocrinol Invest. 40:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kauffman RP, Baker VM, DiMarino P and
Castracane VD: Hyperinsulinemia and circulating
dehydroepiandrosterone sulfate in white and Mexican American women
with polycystic ovary syndrome. Fertil Steril. 85:1010–1016. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fauser BC, Tarlatzis BC, Rebar RW, Legro
RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, et
al: Consensus on women's health aspects of polycystic ovary
syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS
consensus workshop group. Fertil Steril. 97:28–38.e25. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ehrmann DA, Liljenquist DR, Kasza K, Azziz
R, Legro RS and Ghazzi MN; PCOS/Troglitazone Study Group, :
Prevalence and predictors of the metabolic syndrome in women with
polycystic ovary syndrome. J Clin Endocrinol Metab. 91:48–53. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhattacharya SM: Prevalence of metabolic
syndrome in women with polycystic ovary syndrome, using two
proposed definitions. Gynecol Endocrinol. 26:516–520. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Soares EM, Azevedo GD, Gadelha RG, Lemos
TM and Maranhão TM: Prevalence of the metabolic syndrome and its
components in Brazilian women with polycystic ovary syndrome.
Fertil Steril. 89:649–655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Madani T, Hosseini R, Ramezanali F,
Khalili G, Jahangiri N, Ahmadi J, Rastegar F and Zolfaghari Z:
Metabolic syndrome in infertile women with polycystic ovarian
syndrome. Arch Endocrinol Metab. 60:199–204. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vural B, Caliskan E, Turkoz E, Kilic T and
Demirci A: Evaluation of metabolic syndrome frequency and premature
carotid atherosclerosis in young women with polycystic ovary
syndrome. Hum Reprod. 20:2409–2413. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carmina E, Napoli N, Longo RA, Rini GB and
Lobo RA: Metabolic syndrome in polycystic ovary syndrome (PCOS):
lower prevalence in southern Italy than in the USA and the
influence of criteria for the diagnosis of PCOS. Eur J Endocrinol.
154:141–145. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stepto NK, Cassar S, Joham AE, Hutchison
SK, Harrison CL, Goldstein RF and Teede HJ: Women with polycystic
ovary syndrome have intrinsic insulin resistance on
euglycaemic-hyperinsulaemic clamp. Hum Reprod. 28:777–784. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moghetti P, Tosi F, Bonin C, Di Sarra D,
Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall'Alda
M, et al: Divergences in insulin resistance between the different
phenotypes of the polycystic ovary syndrome. J Clin Endocrinol
Metab. 98:E628–E637. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dumesic DA, Oberfield SE, Stener-Victorin
E, Marshall JC, Laven JS and Legro RS: Scientific statement on the
diagnostic criteria, epidemiology, pathophysiology, and molecular
genetics of polycystic ovary syndrome. Endocr Rev. 36:487–525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baptiste CG, Battista MC, Trottier A and
Baillargeon JP: Insulin and hyperandrogenism in women with
polycystic ovary syndrome. J Steroid Biochem Mol Biol. 122:42–52.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dumesic DA, Akopians AL, Madrigal VK,
Ramirez E, Margolis DJ, Sarma MK, Thomas AM, Grogan TR, Haykal R,
Schooler TA, et al: Hyperandrogenism accompanies increased
intra-abdominal fat storage in normal weight polycystic ovary
syndrome women. J Clin Endocrinol Metab. 101:4178–4188. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de Zegher F, Lopez-Bermejo A and Ibáñez L:
Adipose tissue expandability and the early origins of PCOS. Trends
Endocrinol Metab. 20:418–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Unger RH, Clark GO, Scherer PE and Orci L:
Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim
Biophys Acta. 1801:209–214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mannerås-Holm L, Leonhardt H, Kullberg J,
Jennische E, Odén A, Holm G, Hellström M, Lönn L, Olivecrona G,
Stener-Victorin E, et al: Adipose tissue has aberrant morphology
and function in PCOS: enlarged adipocytes and low serum
adiponectin, but not circulating sex steroids, are strongly
associated with insulin resistance. J Clin Endocrinol Metab.
96:E304–E311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rosenfield RL, Ehrlich EN and Cleary RE:
Adrenal and ovarian contributions to the elevated free plasma
androgen levels in hirsute women. J Clin Endocrinol Metab.
34:92–98. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Futterweit W and Deligdisch L:
Histopathological effects of exogenously administered testosterone
in 19 female to male transsexuals. J Clin Endocrinol Metab.
62:16–21. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dunaif A, Segal KR, Futterweit W and
Dobrjansky A: Profound peripheral insulin resistance, independent
of obesity, in polycystic ovary syndrome. Diabetes. 38:1165–1174.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barbieri RL, Makris A, Randall RW, Daniels
G, Kistner RW and Ryan KJ: Insulin stimulates androgen accumulation
in incubations of ovarian stroma obtained from women with
hyperandrogenism. J Clin Endocrinol Metab. 62:904–910. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cara JF and Rosenfield RL: Insulin-like
growth factor I and insulin potentiate luteinizing hormone-induced
androgen synthesis by rat ovarian thecal-interstitial cells.
Endocrinology. 123:733–739. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosenfield RL, Barnes RB, Cara JF and
Lucky AW: Dysregulation of cytochrome P450c 17 alpha as the cause
of polycystic ovarian syndrome. Fertil Steril. 53:785–791. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ehrmann DA, Rosenfield RL, Barnes RB,
Brigell DF and Sheikh Z: Detection of functional ovarian
hyperandrogenism in women with androgen excess. N Engl J Med.
327:157–162. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
González F, Rote NS, Minium J and Kirwan
JP: Reactive oxygen species-induced oxidative stress in the
development of insulin resistance and hyperandrogenism in
polycystic ovary syndrome. J Clin Endocrinol Metab. 91:336–340.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Suresh S and Vijayakumar T: Correlations
of insulin resistance and serum testosterone levels with LH:FSH
ratio and oxidative stress in women with functional ovarian
hyperandrogenism. Indian J Clin Biochem. 30:345–350. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nisenblat V and Norman RJ: Androgens and
polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes.
16:224–231. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rosenfield RL and Ehrmann DA: The
pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of
pcos as functional ovarian hyperandrogenism revisited. Endocr Rev.
37:467–520. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Azziz R: Diagnostic criteria for
polycystic ovary syndrome: a reappraisal. Fertil Steril.
83:1343–1346. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rodrigues JK, Navarro PA, Zelinski MB,
Stouffer RL and Xu J: Direct actions of androgens on the survival,
growth and secretion of steroids and anti-Müllerian hormone by
individual macaque follicles during three-dimensional culture. Hum
Reprod. 30:664–674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Azziz R, Carmina E, Dewailly D,
Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen
OE, Legro RS, Norman RJ, Taylor AE, et al: Task Force on the
Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess
and PCOS Society: The androgen excess and PCOS society criteria for
the polycystic ovary syndrome: the complete task force report.
Fertil Steril. 91:456–488. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Homburg R: Pregnancy complications in
PCOS. Best Pract Res Clin Endocrinol Metab. 20:281–292. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bjercke S, Dale PO, Tanbo T, Storeng R,
Ertzeid G and Abyholm T: Impact of insulin resistance on pregnancy
complications and outcome in women with polycystic ovary syndrome.
Gynecol Obstet Invest. 54:94–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Weerakiet S, Srisombut C, Rojanasakul A,
Panburana P, Thakkinstian A and Herabutya Y: Prevalence of
gestational diabetes mellitus and pregnancy outcomes in Asian women
with polycystic ovary syndrome. Gynecol Endocrinol. 19:134–140.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Anttila L, Karjala K, Penttilä RA,
Ruutiainen K and Ekblad U: Polycystic ovaries in women with
gestational diabetes. Obstet Gynecol. 92:13–16. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Turhan NO, Seçkin NC, Aybar F and Inegöl
I: Assessment of glucose tolerance and pregnancy outcome of
polycystic ovary patients. Int J Gynaecol Obstet. 81:163–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD
and Chen HY: Obstetric complications in women with polycystic ovary
syndrome: a systematic review and meta-analysis. Reprod Biol
Endocrinol. 11:562013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Glueck CJ, Wang P, Goldenberg N and
Sieve-Smith L: Pregnancy outcomes among women with polycystic ovary
syndrome treated with metformin. Hum Reprod. 17:2858–2864. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Glueck CJ, Wang P, Kobayashi S, Phillips H
and Sieve-Smith L: Metformin therapy throughout pregnancy reduces
the development of gestational diabetes in women with polycystic
ovary syndrome. Fertil Steril. 77:520–525. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ghazeeri GS, Nassar AH, Younes Z and Awwad
JT: Pregnancy outcomes and the effect of metformin treatment in
women with polycystic ovary syndrome: an overview. Acta Obstet
Gynecol Scand. 91:658–678. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nawaz FH, Khalid R, Naru T and Rizvi J:
Does continuous use of metformin throughout pregnancy improve
pregnancy outcomes in women with polycystic ovarian syndrome? J
Obstet Gynaecol Res. 34:832–837. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Costello MF and Eden JA: A systematic
review of the reproductive system effects of metformin in patients
with polycystic ovary syndrome. Fertil Steril. 79:1–13. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jakubowicz DJ, Iuorno MJ, Jakubowicz S,
Roberts KA and Nestler JE: Effects of metformin on early pregnancy
loss in the polycystic ovary syndrome. J Clin Endocrinol Metab.
87:524–529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ben-Haroush A, Yogev Y and Hod M:
Epidemiology of gestational diabetes mellitus and its association
with type 2 diabetes. Diabet Med. 21:103–113. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Eckel RH, Grundy SM and Zimmet PZ: The
metabolic syndrome. Lancet. 365:1415–1428. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rossi B, Sukalich S, Droz J, Griffin A,
Cook S, Blumkin A, Guzick DS and Hoeger KM: Prevalence of metabolic
syndrome and related characteristics in obese adolescents with and
without polycystic ovary syndrome. J Clin Endocrinol Metab.
93:4780–4786. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Apridonidze T, Essah PA, Iuorno MJ and
Nestler JE: Prevalence and characteristics of the metabolic
syndrome in women with polycystic ovary syndrome. J Clin Endocrinol
Metab. 90:1929–1935. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bil E, Dilbaz B, Cirik DA, Ozelci R,
Ozkaya E and Dilbaz S: Metabolic syndrome and metabolic risk
profile according to polycystic ovary syndrome phenotype. J Obstet
Gynaecol Res. 42:837–843. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Abruzzese GA, Cerrrone GE, Gamez JM,
Graffigna MN, Belli S, Lioy G, Mormandi E, Otero P, Levalle OA and
Motta AB: Lipid accumulation product (LAP) and visceral adiposity
index (VAI) as markers of insulin resistance and metabolic
associated disturbances in young argentine women with polycystic
ovary syndrome. Horm Metab Res. 49:23–29. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Turkmen S, Ahangari A and Bäckstrom T:
Roux-en-y gastric bypass surgery in patients with polycystic ovary
syndrome and metabolic syndrome. Obes Surg. 26:111–118. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Legro RS, Dodson WC, Kris-Etherton PM,
Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming
J, Allison KC, et al: Randomized controlled trial of preconception
interventions in infertile women with polycystic ovary syndrome. J
Clin Endocrinol Metab. 100:4048–4058. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Colilla S, Cox NJ and Ehrmann DA:
Heritability of insulin secretion and insulin action in women with
polycystic ovary syndrome and their first degree relatives. J Clin
Endocrinol Metab. 86:2027–2031. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wu S, Divall S, Nwaopara A, Radovick S,
Wondisford F, Ko C and Wolfe A: Obesity-induced infertility and
hyperandrogenism are corrected by deletion of the insulin receptor
in the ovarian theca cell. Diabetes. 63:1270–1282. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Codner E and Escobar-Morreale HF: Clinical
review: hyperandrogenism and polycystic ovary syndrome in women
with type 1 diabetes mellitus. J Clin Endocrinol Metab.
92:1209–1216. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Facchinetti F, Bizzarri M, Benvenga S,
D'Anna R, Lanzone A, Soulage C, Di Renzo GC, Hod M, Cavalli P, Chiu
TT, et al: Results from the International Consensus Conference on
myo-inositol and d-chiro-inositol in obstetrics and gynecology: the
link between metabolic syndrome and PCOS. Eur J Obstet Gynecol
Reprod Biol. 195:72–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ehrmann DA, Breda E, Corcoran MC, Cavaghan
MK, Imperial J, Toffolo G, Cobelli C and Polonsky KS: Impaired
beta-cell compensation to dexamethasone-induced hyperglycemia in
women with polycystic ovary syndrome. Am J Physiol Endocrinol
Metab. 287:E241–E246. 2004. View Article : Google Scholar : PubMed/NCBI
|
